Problems with computers could be blamed for up to 900 patient deaths in the NHS a year, experts have said.
Computers are embedded across the NHS but many are "bad" and "low quality", according to two academics
Equiteq, the knowledge economy M&A specialist, is pleased to announce that it has advised Insight Strategy Advisors (ISA), a premier life sciences strategy consultancy, on its sale to Precision Value & Health, a part of Precision Medicine Group. ISA will become part of Precision Xtract, the global market access consultancy within Precision Value & Health.
NEHI puts a price on patients not adhering to treatment. It’s $290 Billion worth of a new problem for the pharmaceuticals industry – getting beyond the pill to influence the behaviours or patients and thereby influence the outcomes on which their reimbursements, and ultimately profitability, depends. Investment in patient access and adherence technology and programs is set to increase exponentially over the next five years, but if this investment is going to pay off, the data strategy to understand what patients are doing (or not doing) and why needs to be clear.
Finally it’s a reality that EU Pricing is contagious – and the US market is already showing some early symptoms including cold sweats, bouts of litigiousness, and the kind of migraine that can only be brought on by Risk Sharing Agreements.
Real-world Evidence is should be the pilot of new drug development, and it's already a business class priority. So why is so much RWE thinking still flying economy?
The Cancer Drugs Fund achieved many of its aims. It transformed access to breakthrough oncology drugs in the UK, and brought the NHS closer to the levels of access seen elsewhere in Europe. If someone had pointed to the elephant in the room, it might still be here in it's former shape.
The value assessment frameworks introduced into the US in 2015 take a very static view of value, or more precisely value demonstration. By not considering Real-world evidence alongside trials data these new frameworks risk pushing the industry into a stalemate – increasingly complex commercial models, which are not then supported and enabled by a value assessment process which recognizes sub-populations of patients. Put simply, next-generation sequencing in genomics has pushed the envelope while definitions of value are still preoccupied with franking the mail.
The proper use of medicines could save the US healthcare system $213 billion annually, according to Joseph Jimenez, CEO of Novartis, in an article for the World Economic Forum. He goes on to say that, based on research, US healthcare costs could be reduced by 25% if health systems and policymakers could stop treatments that aren't working.
The modern Chinese consumer is healthier, less materialistic and more partial to home-grown brands than ever before, according to research from market analysts in Britain.
220,000 commuters, tourists, and the just plain lost travel on the London tube's Northern Line every day between 5pm and 7pm. Unless it's a Thursday when it's 219,999 as I work from home. Thanks to a wifi connection I can reduce the burden on the creaking underground system by a (very) marginal amount. And my own stress levels by a very unmarginal amount.
-London leads Europe for life sciences investment in 2017
- Companies raised £909m investment in 2017 and £2.8bn over the past five years
- 63% of the UK’s life sciences investment landed in ‘The Golden Triangle’ of London, Oxford and Cambridge
Vegetarianism and organic food are on the rise in China’s wealthier cities.
China’s heavily-laden banquet tables are under threat from changing tastes as the country’s growing middle class indulges in lighter, healthier foods.
Consulting attracts intellectual individuals, and those individuals collectively form the core product of a management consultancy. Packaging the knowledge and skills of its people, and delivering these skills through services and solutions, creates differentiation for a consulting firm.
When Raymond C. Stevens moved to Shanghai in 2011 for a nine-month sabbatical, he was curious. After spending his career in the United States, establishing a laboratory at the University of Southern California in Los Angeles and three biotechnology start-ups, the chemist sensed that China might be the next research frontier.
Funding that was put aside to stabilise NHS finances and support sustainability and transformation partnerships (STPs) has instead been spent on helping the service cope with immediate pressures and day-to-day costs, the government’s financial regulator has today reported.
The city government is today asking for proposals on how to use $100 million in funds and city land to create a "life sciences hub" with the goal of making the city competitive with Boston and San Francisco as a place to start biotechnology companies. The money is part of $500 million in resources the city has earmarked to draw biotech investment.
As more residents of China become flush with disposable income, they’re likely to spend more on goods and services delivering an improved lifestyle.
Hospitals remain under intense pressure this winter from flu and illness caused by the cold weather, NHS England figures show.
A&E units had to divert patients to other hospitals 20 times last week, and more than 11,000 patients had to be looked after by ambulance crews for at least half an hour before they could be handed over to A&E nurses.
The post-crisis crackdown by watchdogs imposed severe pain on all but one area of the financial services industry: the consultants whose regulatory divisions enjoyed a golden decade helping banks and other clients to keep pace with ever-changing demands.
Public Health England is launching a review into the "growing problem" of prescription drug addiction.
NHS data suggest one in every 11 patients in England is being prescribed medication that could be addictive, or difficult to come off.